© 2004 by European Society of Cardiology
Copyright © 2004, European Society of Cardiology
Ghrelin in the heart and growth hormone: which is chicken, which is egg?
INSERM Unité 581, Hôpital Henri Mondor 94010 Créteil, France
* Tel.: +33-149-813534; fax: +33-148-980908. Email address: pecker@im3.inserm.fr
Received 5 March 2004; accepted 10 March 2004
| The first 10% of the full text of this article appears below. |
In their study published in this issue, Iglesias et al. give the first evidence that ghrelin is synthesized and secreted by cardiomyocytes. Ghrelin is a 28-amino acid peptide containing an n-octanoyl modification at serine 3. It acts on the pituitary and hypothalamus to stimulate growth hormone (GH) release, food intake, and adiposity. It has been newly identified as the endogenous ligand of the orphan GH secretagogues (GHS) receptor, GHSR-1a, that is mostly expressed in pituitary and hypothalamus. Acylation of ghrelin is required for activation of GHSR-1a, whereas des-acyl ghrelin, which is far more abundant than ghrelin, does not bind GHSR-1a and is devoid of any endocrine activity [1,2].
GH and its mediator, insulin-like growth factor (IGF)-1, are anabolic hormones that
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. R. Kraemer and V. D. Castracane Exercise and Humoral Mediators of Peripheral Energy Balance: Ghrelin and Adiponectin Experimental Biology and Medicine, February 1, 2007; 232(2): 184 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Marleau, M. Mulumba, D. Lamontagne, and H. Ong Cardiac and peripheral actions of growth hormone and its releasing peptides: Relevance for the treatment of cardiomyopathies Cardiovasc Res, January 1, 2006; 69(1): 26 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Henriques-Coelho, J. Correia-Pinto, R. Roncon-Albuquerque Jr, M. J. Baptista, A. P. Lourenco, S. M. Oliveira, A. Brandao-Nogueira, A. Teles, J. M. Fortunato, and A. F. Leite-Moreira Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2885 - H2890. [Abstract] [Full Text] [PDF] |
||||


